146 related articles for article (PubMed ID: 19846820)
21. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
22. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
Walts AE; Thomas P
Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
[TBL] [Abstract][Full Text] [Related]
23. Performance and reproducibility of gynecologic cytology interpretation using the FocalPoint system: results of the RODEO Study Team.
Stein MD; Fregnani JH; Scapulatempo C; Mafra A; Campacci N; Longatto-Filho A;
Am J Clin Pathol; 2013 Oct; 140(4):567-71. PubMed ID: 24045555
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
Cengel KA; Day SJ; Davis-Devine S; Adams CL; Madison-Henness D; Hartman ME; Freund GG
Diagn Cytopathol; 2003 Nov; 29(5):250-5. PubMed ID: 14595790
[TBL] [Abstract][Full Text] [Related]
25. Assessment of manual workload limits in gynecologic cytology: reconciling data from 3 major prospective trials of automated screening devices.
Renshaw AA; Elsheikh TM
Am J Clin Pathol; 2013 Apr; 139(4):428-33. PubMed ID: 23525612
[TBL] [Abstract][Full Text] [Related]
26. Is there a role for the thinprep imaging system in reporting anal cytology?
Margaret Roberts J; Jin F; Ekman D; Kay Adams M; Lindsay McDonald R; Kathleen Thurloe J; Richards A; Mary Poynten I; Law C; Kincaid Fairley C; John Hillman R; Tabrizi SN; Marie Cornall A; James Templeton D; Marie Garland S; Edwin Grulich A; Farnsworth A
Diagn Cytopathol; 2016 May; 44(5):384-8. PubMed ID: 26876374
[TBL] [Abstract][Full Text] [Related]
27. A novel optical imaging method for the early detection, quantitative grading, and mapping of cancerous and precancerous lesions of cervix.
Balas C
IEEE Trans Biomed Eng; 2001 Jan; 48(1):96-104. PubMed ID: 11235596
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the FocalPoint GS system performance in an Italian population-based screening of cervical abnormalities.
Passamonti B; Bulletti S; Camilli M; D'Amico MR; Di Dato E; Gustinucci D; Martinelli N; Malaspina M; Spita N
Acta Cytol; 2007; 51(6):865-71. PubMed ID: 18077978
[TBL] [Abstract][Full Text] [Related]
29. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
Renshaw AA; Deschênes M; Auger M
Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
[TBL] [Abstract][Full Text] [Related]
30. Automated screening of conventional gynecological cytology smears: feasible and reliable.
Saieg MA; Motta TH; Fodra ME; Scapulatempo C; Longatto-Filho A; Stiepcich MM
Acta Cytol; 2014; 58(4):378-82. PubMed ID: 25195537
[TBL] [Abstract][Full Text] [Related]
31. The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.
Kardos TF
Cancer; 2004 Dec; 102(6):334-9. PubMed ID: 15549692
[No Abstract] [Full Text] [Related]
32. Accuracy of ThinPrep Imaging System in detecting low-grade squamous intraepithelial lesions.
Zhang FF; Banks HW; Langford SM; Davey DD
Arch Pathol Lab Med; 2007 May; 131(5):773-6. PubMed ID: 17488164
[TBL] [Abstract][Full Text] [Related]
33. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
34. Dissemination of Lean methods to improve Pap testing quality and patient safety.
Raab SS; Andrew-Jaja C; Grzybicki DM; Vrbin CM; Chesin CM; Fisch JM; Dabbs DJ; Sommer DL; Blaser SM
J Low Genit Tract Dis; 2008 Apr; 12(2):103-10. PubMed ID: 18369303
[TBL] [Abstract][Full Text] [Related]
35. Calibration of the Becton Dickinson FocalPoint GS slide profiler is essential for optimal performance: Avoiding the algorithm supersaturation cascade effect pitfall.
Nuttall DS; Anderson WJ; Savage AJ; Denton K; Martin CM; O'Leary JJ
Cancer Cytopathol; 2023 Jun; 131(6):383-391. PubMed ID: 36973942
[TBL] [Abstract][Full Text] [Related]
36. Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study.
Stein MD; Fregnani JH; Scapulatempo-Neto C; Longatto-Filho A
Diagn Pathol; 2015 Jan; 10():1. PubMed ID: 25591792
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in optical imaging for cervical cancer detection.
Orfanoudaki IM; Kappou D; Sifakis S
Arch Gynecol Obstet; 2011 Nov; 284(5):1197-208. PubMed ID: 21800084
[TBL] [Abstract][Full Text] [Related]
38. Automated screening versus manual screening: a comparison of the ThinPrep imaging system and manual screening in a time study.
Schledermann D; Hyldebrandt T; Ejersbo D; Hoelund B
Diagn Cytopathol; 2007 Jun; 35(6):348-52. PubMed ID: 17497655
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 100% rapid rescreening of cervical smears.
Sood N; Singh V
Indian J Pathol Microbiol; 2009; 52(4):495-7. PubMed ID: 19805954
[TBL] [Abstract][Full Text] [Related]
40. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
Seppo A; Jalali GR; Babkowski R; Symiakaki H; Rodolakis A; Tafas T; Tsipouras P; Kilpatrick MW
Gynecol Oncol; 2009 Jul; 114(1):80-3. PubMed ID: 19394683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
